Updates on intravesical therapy. Issue 6 (November 2019)

• Record Type: Journal Article
• Authors: Pisano, Francesca; Vila Reyes, H.; Breda, A.; Palou, J.
• Is Part Of: Current opinion in urology. Volume 29:Issue 6(2019:Nov.)
• Publication Date: 2019-11
• Subjects: chemotherapy -- immunotherapy -- intravesical treatment -- nonmuscle invasive bladder cancer -- urothelial carcinoma; Urology -- Periodicals; Review Literature -- Bibliography; Review Literature -- Periodicals; Male Urogenital Diseases -- Bibliography; Male Urogenital Diseases -- Periodicals; Female Urogenital Diseases -- Bibliography; Female Urogenital Diseases -- Periodicals; Urologic Diseases -- Bibliography; Urologic Diseases -- Periodicals; Periodicals; 616.6005
• DOI: 10.1097/MOU.0000000000000679
• Languages: English
• ISSNs: 1473-6586

Abstract

Abstract : Purpose of review: To review the current literature concerning the intravesical treatment of nonmuscle invasive bladder cancer. Recent findings: Bladder cancer is a high prevalent disease. Despite the recognized efficacy of traditional intravesical therapies, the best treatment strategy still needs to be found. Improvement in bladder cancer research lead to develop new intravesical agents and drug delivery systems for nonmuscle invasive bladder cancer tumours. Moreover, the emerging knowledge of bladder cancer immune profile strongly improves and provides new available treatment strategies. Summary: The future of nonmuscle invasive bladder cancer therapy will be influenced by the development of immunotherapy and new technologies for device-assisted treatment. Moreover, nanotechnology and delivery systems present promising results.